Member Info for craiga24

the science is amazing and never been happier to hold but i never thought today was going to move the sp. i still think its is seen as "yeah thats great but how you funding it moving forward" and thats why we are where we are with the sp. you can have something amazing but if you dont have the investment to develop it you are stuffed. i know that opinion will **** people off (i dont care).

in my opinion we have 4 things that could happen within the next 6 months that will move the sp .1 an rns about fda fast track, peer reviewed data of all of p1a, licencing deals or to, significant media attention.

having said that what avacta have accomplished is amazing and congrats to all staff but its gonna require a little more patience from shareholders.

no negatives in that rns for me (seemed a lot of confirmation on what was already known, or expanded on more, like the patient we knew had tumour reduction from previous rns )this rns was just the next step and i will have no problem buying more when funds allow

Now have a keyboard full of spat out coffee thanks NYsize ;-)

I am not expecting any kind of rerate on Wednesday (based on the data alone). I think those that think the data release is going to propel this over £2 are are going to be very dissapointed. Reading the clear pumping from ofraudian with his HP and the other fellow clowns is like dejavu (What pump are we on 10? 11? in the last 4 years), they have been wrong and full of BS on so many occasions its unreal. If you are new to avacta stick to what is in the RNS not their fantasy BS.

Having said that if the data on wednesday is backed up with any type of licencing deal (Although persoanlly I think unlikely until early next year) then yeah it could be a good xmas but on data alone I still think as I said back in July we finish the year at £1.50 - £1.80.

I think the data will be excellent and backup all the comments from the company and we will see a tick up but I just dont see the rerate until the financial side is solid (however that may come about). Baby steps is fine with me. I have been here 4 years I can wait. No point in chemo without side effects if you cant fund the development going forward. I hate to agree with Wyndrum but he is right the share price does not lie, if everything was the slam dunk that some bell ends tell you it is we would not be sat at 1.30. (I dont buy the thick as mince $hit either)

Looking forward to Wednesday.

When the stock exchange turns the internet back on?

Is Zeus capital that richard hughes fella and boohoo guy or have I got the wrong company

Simple really... I aint that brave, my luck would be a RNS drops (I dont have 100s of 1000s of shares to play with) but if you are telling me in the past 4 years you have not seen a repeated pattern of pump, dump, rebuy from some quaters I cant help you apart from recommending a visit to specsavers

Or maybe its those that sold at 1.35+ buying back in after making a nice little profit (*cough cough twitter pump and sell crew, happens every few months or are we just ignoring the obvious nowadays ;-)) just a thought anyway

"Long term holders do not really care about funding."

Stupidest comment of the year award goes to you. I am a long term holder and I do care, if you dont care about how the company is going to push itself forward than you are clearly an idiot (looking at some of the tripe you have posted over the past year think I will just filter you rather than debate with you. Good luck with your "Hundreds of Thousands" fantasy holding ). Avacta are on the cusp of something amazing but I think a magic money tree is even beyond them.

12.7

I am sure at the AGM he said they were staring to see signs in patients that MTD was close and although they could go beyond 7 it was unlikely because they were starting to see signs in cohort 5

watching you talk some right ****e. finally popping your waffling a$$ in the bin.

"Its like me saying I would not expect to get any insults for this post."

Fair point

You are a twat

- End of year? £1.50 - £1.80 (I think some news by year end will give us a bump but dont expect a re-rate this year)

- Early next year when I expect we start 1b £1.80 -£2.50 (good price movement on 1a data but again not a full rerate imho )

- 6-9 months into 1b (so maybe Aug 2024 onwards) when I expect we start to see some 1b data as suggested at AGM - Pick a

number between £3 and £15 if the data is looking good, this is when I think we see the market start to value avacta

- Allowed to complete 1b without been taken over / it going to $hit or a takeover by BP - Pick a number between £15 and £50

Lots of bumpy times ahead and possibly a placing at some point in the future (this is about the only point I agree with wyntwat on) unless a licence deal is in the pipeline (nobody knows everyone is just speculating) - but if I recall AL said its not likely to be below £1 if there was a placing so stick your 20p raise up your a$$. If you have the patience to hold I think avacta is on the cusp of something special over the next 12 - 24 months. Just my opinion I know as much in terms of "facts" as eveyone else, it could go to $hit but doubt it.

The guy is clearly a twat. It was obvious to me from day 1 with his copy and paste rampy trash and its even more evident now he has suddenly "sold " his imaginary shares in a company that not so long ago was the best thing since Yorkshire tea becasue of all the research he did (thats all suddenly wrong as there are competitors like there are in every field).

Come on guys I know some of you have been here as long and longer than me, we have seen this type of ball bag come and go. Green bin it where it belongs.

Cheers Hanoihank maybe I should learn to read :-)

"second milestone equity payment "

Do we have any idea how much the milestone payment was? Just wondering if knowing this payment was on its way was the reason for the covis buyout (ie the enough funding to last 18 months is then still true)

Doubt it.

https://www.mskcc.org/cancer-care/doctors/william-tap#clinical-trials

Agree with very pleased. I've been invested in avacta 3.5 years and commercially he has delivered very little for shareholders. 500k does sting a little as a shareholder to me. Having said that IF he delivers take all the bonus you want Al. but what has he delivered so far for shareholders? (No rampy s hite about the future progress please I'm talking about delivered to date that has benefitted shareholders)

Knowing my luck he will release an rns for a monster licensing deal next week and I'll have to send him a big bunch of flowers but until then... meh to the 500k

Thanks gadgie I was looking for that earlier.

"Wynitas - Come see us, operating worldwide - there is no law saying you cant be bored to death"